Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-04-04
1990-05-29
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3134
Patent
active
049296400
ABSTRACT:
A new composition, useful as a medicament, contains ascorbate, preferably as metallic salt(s), in combination with a dopamine agonist such as bromocriptine, with the ratio by weight of ascorbate to bromocriptine being 400:1 or greater. This combination, believed to act through stimulation of pituitary production of somatotropin, has a significant ability to stimulate enhanced lymphocyte function. Other useful dopamine agonists include lergotrile and pergolide.
REFERENCES:
patent: 2269145 (1942-01-01), Culter et al.
patent: 3840562 (1974-11-01), Richardson
patent: 3887705 (1975-06-01), Serre et al.
patent: 3896228 (1975-07-01), Richardson
patent: 4220636 (1980-09-01), Duscher
patent: 4336145 (1982-12-01), Stoopak et al.
patent: 4462983 (1984-07-01), Azria et al.
Friedman Stanley J.
McAdory George D.
LandOfFree
Medicaments intended for combined use in the improvement of lymp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicaments intended for combined use in the improvement of lymp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments intended for combined use in the improvement of lymp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-521292